Consensus Recommendations on Adjunctive Topical Management of Atopic Dermatitis
Del Rosso, J.Q.; Harper, J.; Kircik, L.; Albon, G.; Berson, D.; Hebert, A.; Day, D.
Journal of Drugs in Dermatology Jdd 17(10): 1070-1076
2018
ISSN/ISBN: 1545-9616 PMID: 30365587 Document Number: 17627
Atopic dermatitis (AD) is well-recognized as a very common chronic and relapsing pruritic skin disorder affecting both children and adults worldwide. The adverse effects on the quality of life of affected individuals and their families is well-established. The pathophysiology of AD is complex, leading to interindividual variations in clinical presentation and severity. The chronicity of AD, characterized by periods of exacerbation and remission, supports a strong need to develop measures that can effectively and safely prolong remissions between flares of the disease. This article provides an overview of AD including prevalence, severity, and disease course/progression, succinct summaries of pathophysiology and medical management, and discussion of epidermal barrier dysfunction and skin microbiome shifting associated with AD. Additional emphasis is placed on adjunctive topical skin barrier approaches that may prolong disease-free remissions. Results from a panel of dermatologists queried about adjunctive approaches to AD, using a modified-Delphi approach, are also discussed.
Document emailed within 1 workday
